William Collins > Goodwin > Boston, United States > Lawyer Profile

Goodwin
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
William Collins photo

Position

Partner

Career

William Collins is a partner in Goodwin’s nationally recognized Life Sciences group, counseling clients in the industries of biotechnology, pharmaceuticals and medical devices. Serving as his clients’ principal outside counsel, William provides strategic advice and corporate legal counseling to management teams and boards while structuring and leading significant transactions on his clients’ behalf. He is recognized by his clients and colleagues for his extensive industry knowledge and deal experience, and for providing practical legal and business advice. William has also been recognized as one of Law360’s Rising Stars for 2022.

William has extensive experience with startup and formation matters, venture capital financings, initial public offerings, deSPAC transactions and other equity debt capital markets transactions, mergers and acquisitions, strategic collaborations, and other complex transactions. He also represents a number of publicly traded biotechnology companies in ongoing SEC compliance, capital raising and corporate governance matters.

William has advised many of his clients through their full corporate life cycle, starting with their initial founding and funding. He also regularly represents leading venture capital firms focused on the life sciences industry in connection with their portfolio company investments, exits and secondary stock sale transactions.

Education

JD, 2009, Boston University School of Law (cum laude) / BS, 2006, The University of Texas at Dallas (cum laude)

Lawyer Rankings

United States > M&A/corporate and commercial > Venture capital and emerging companies

(Next Generation Partners)

William Collins – Goodwin

Goodwin provides a full-service offering to emerging companies and venture capital companies, supporting clients from initial seed financing stages through to exit transactions. The life sciences practice is co-chaired by Mitch Bloom and Kingsley Taft from Boston, and the technology and emerging companies team is jointly led by Kenneth Gordon in Boston and Craig Schmitz in New York. Bill Schnoor, based in Boston, specializes in business and securities law, private equity work, and acquisitions. Danielle Lauzon, who focuses on life sciences and healthcare information technology services clients, and William Collins, who is experienced in formations, capital markets transactions and exit strategies, bolster the Boston team. In Silicon Valley, Caine Moss assists companies in the software, AI, internet, and financial services sectors.